Assessment of urinary metanephrine and normetanephrine fractionation analyses as aids in the antemortem diagnosis of pheochromocytomas in clouded leopards (Neofelis nebulosa)
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.25.01.0033 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Peter A Sojka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Avian and Exotics Department, Pieper Memorial Veterinary Hospital, Middletown, CT. Hauptthemen laut MEDLINE: Pheochromocytoma, Metanephrine, Normetanephrine, Adrenal Gland Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To examine the normetanephrine- and metanephrine-to-creatinine urinary fractionation ratios of clouded leopards ( Neofelis nebulosa ) at various ages. We hypothesized that clouded leopards with large metanephrine- and/or normetanephrine-to-creatinine fractionation ratios would have a pheochromocytoma on postmortem examination. Those subjects with comparatively smaller fractionation ratios would not have a pheochromocytoma on postmortem examination.
Methods
Clouded leopards housed at a zoological institution or sanctuary were included in this study. Patients were examined within a hospital environment. All samples were obtained from January 2020 through August 2021. Urine was collected from patients by direct free catch, cystocentesis, or urinary catheterization and analyzed for metanephrine- and normetanephrine-to-creatinine fractionation ratios. Postmortem examinations were performed on animals that died naturally or were euthanized for various comorbidities to determine if a pheochromocytoma was present.
Results
This experimental study included 1- to 16-year-old clouded leopards, 11 male and 6 female, managed under human care. The 2 clouded leopards in this study with normetanephrine- or metanephrine-to-creatinine fractionation ratios greater than 4 times the high end of the ranges identified in the subjects of this study had confirmed pheochromocytomas on postmortem examination.
Conclusions
Normetanephrine- and metanephrine-to-creatinine fractionation testing may be useful tools in the antemortem diagnosis of pheochromocytomas in clouded leopards. Clinical Relevance Normetanephrine- and metanephrine-to-creatinine fractionation testing may provide a minimally invasive antemortem method of screening for pheochromocytomas in clouded leopards. Quantitative studies are needed to determine if this testing is consistently able to diagnose pheochromocytoma in live clouded leopards.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Avian and Exotics Department, Pieper Memorial Veterinary Hospital, Middletown, CT.
- College of Veterinary Medicine, University of Tennessee, Knoxville, TN.
- Nashville Zoo at Grassmere, Nashville, TN.
Zitieren
APA
Sojka, P. A., Cushing, A., Martinelli, L., Schwartz, H., Zhu, X., & Ramsay, E. C. (2025). Assessment of urinary metanephrine and normetanephrine fractionation analyses as aids in the antemortem diagnosis of pheochromocytomas in clouded leopards (Neofelis nebulosa). American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.01.0033
Vancouver
Sojka PA, Cushing A, Martinelli L, Schwartz H, Zhu X, Ramsay EC. Assessment of urinary metanephrine and normetanephrine fractionation analyses as aids in the antemortem diagnosis of pheochromocytomas in clouded leopards (Neofelis nebulosa). American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.01.0033
BibTeX
@article{Sojka2025,
author = {Sojka, Peter A and Cushing, Andrew and Martinelli, Laura and Schwartz, Heather and Zhu, Xiaojuan and Ramsay, Edward C},
title = {Assessment of urinary metanephrine and normetanephrine fractionation analyses as aids in the antemortem diagnosis of pheochromocytomas in clouded leopards (Neofelis nebulosa)},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.25.01.0033}
}
EUVIMED